Candel Therapeutics, Inc. · NASDAQ:CADL

Candel Therapeutics, Inc. shareholders

As of Sep 30, 2026, 137 institutions reported holding Candel Therapeutics, Inc., 64.9% of its shares. Largest: Fidelity, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Candel Therapeutics, Inc.ChangeFiled
Fidelity11.6M14.7%+580KNov 10, 2026
BlackRock5.18M6.6%+214KNov 13, 2026
Vanguard4.02M5.1%+442KNov 13, 2026
State Street3.81M4.9%+257KNov 12, 2026
Portolan Capital Management, LLC3.54M4.5%+48,163Nov 16, 2026
Acorn Capital Advisors, LLC3.5M4.5%no changeNov 16, 2026
Saturn V Capital Management LP3.48M4.4%+173KNov 16, 2026
Rtw Investments, LP3.21M4.1%−3.21MNov 16, 2026
Geode Capital1.71M2.2%+135KNov 6, 2026
Millennium971K1.2%−123KNov 16, 2026

Candel Therapeutics, Inc. insider trades